U.S. flag

An official website of the United States government

NM_005060.4(RORC):c.1456T>A (p.Phe486Ile) AND Autosomal recessive mendelian susceptibility to mycobacterial diseases due to complete RORgamma receptor deficiency

Germline classification:
Uncertain significance (1 submission)
Last evaluated:
Sep 10, 2018
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000793258.6

Allele description [Variation Report for NM_005060.4(RORC):c.1456T>A (p.Phe486Ile)]

NM_005060.4(RORC):c.1456T>A (p.Phe486Ile)

Gene:
RORC:RAR related orphan receptor C [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
1q21.3
Genomic location:
Preferred name:
NM_005060.4(RORC):c.1456T>A (p.Phe486Ile)
HGVS:
  • NC_000001.11:g.151807573A>T
  • NG_029118.1:g.29300T>A
  • NM_001001523.2:c.1393T>A
  • NM_005060.4:c.1456T>AMANE SELECT
  • NP_001001523.1:p.Phe465Ile
  • NP_005051.2:p.Phe486Ile
  • LRG_1322t1:c.1456T>A
  • LRG_1322t2:c.1393T>A
  • LRG_1322:g.29300T>A
  • LRG_1322p1:p.Phe486Ile
  • LRG_1322p2:p.Phe465Ile
  • NC_000001.10:g.151780049A>T
  • NM_005060.3:c.1456T>A
Protein change:
F465I
Links:
dbSNP: rs1572032352
NCBI 1000 Genomes Browser:
rs1572032352
Molecular consequence:
  • NM_001001523.2:c.1393T>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_005060.4:c.1456T>A - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Autosomal recessive mendelian susceptibility to mycobacterial diseases due to complete RORgamma receptor deficiency
Synonyms:
Immunodeficiency 42
Identifiers:
MONDO: MONDO:0014710; MedGen: C5567647; OMIM: 616622

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000932604Invitae
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Uncertain significance
(Sep 10, 2018)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Sherloc: a comprehensive refinement of the ACMG-AMP variant classification criteria.

Nykamp K, Anderson M, Powers M, Garcia J, Herrera B, Ho YY, Kobayashi Y, Patil N, Thusberg J, Westbrook M; Invitae Clinical Genomics Group., Topper S.

Genet Med. 2017 Oct;19(10):1105-1117. doi: 10.1038/gim.2017.37. Epub 2017 May 11. Erratum in: Genet Med. 2020 Jan;22(1):240-242.

PubMed [citation]
PMID:
28492532
PMCID:
PMC5632818

Details of each submission

From Invitae, SCV000932604.4

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)

Description

This sequence change replaces phenylalanine with isoleucine at codon 486 of the RORC protein (p.Phe486Ile). The phenylalanine residue is highly conserved and there is a small physicochemical difference between phenylalanine and isoleucine. This variant is not present in population databases (ExAC no frequency). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C15"). This variant has not been reported in the literature in individuals with RORC-related disease.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Feb 20, 2024